M4MM

Curaleaf Reports Revenue Growth in Q2 2024

LOS ANGELES- Curaleaf Holdings, Inc. reported a net loss of $49.8 million for Q2 2024, bringing its year-to-date losses to over $100 million. Despite these losses, the company achieved a 2% increase in revenue, reaching ...

The Cannabist Reports Mixed Q2 2024 Results

LOS ANGELES- The Cannabist Company Holdings Inc. (OTC: CBSTF), formerly known as Columbia Care, delivered a mixed performance for Q2 2024. The company reported $125 million in revenue, a 2% sequential increase but a drop ...

Curaleaf Reports Revenue Growth in Q2 2024

LOS ANGELES- Curaleaf Holdings, Inc. reported a net loss of $49.8 million for Q2 2024, bringing its year-to-date losses to over $100 million. Despite these losses, the company achieved a 2% increase in revenue, reaching ...

The Cannabist Reports Mixed Q2 2024 Results

LOS ANGELES- The Cannabist Company Holdings Inc. (OTC: CBSTF), formerly known as Columbia Care, delivered a mixed performance for Q2 2024. The company reported $125 million in revenue, a 2% sequential increase but a drop ...

Charlotte’s Web Holdings Reports Quarter 1 2021 Results

BOULDER– Charlotte's Web Holdings (TSX: CWEB) (OTCQX: CWBHF), Charlotte's Web Holdings, Inc. the market share leader in full spectrum cannabidiol (CBD) hemp extract wellness products, today reported financial results for the first quarter ended March ...

Cardiol Therapeutics Closes $22 Million Bought Deal Offering

ONTARIO–Cardiol Therapeutics Inc. (TSX: CRDL), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease, is pleased to announce the closing of its previously announced "bought deal" short form prospectus ...

Subscribe To Our Newsletter